This story has been updated to correct a comment by Diana Marcella Cardona that was mischaracterized in the original version. We regret the error. NEW YORK ...

NEW YORK – During a webcast presentation at the 44 th Annual JP Morgan Healthcare Conference in San Francisco on Monday, Qiagen CEO Theirry Bernard projected a near-term revival of lab equipment ...

ANAHEIM, Calif. — Point-of-care firm Kompass Diagnostics took first place in the Disruptive Technology Award Competition at the Association for Diagnostics & Laboratory Medicine's annual meeting here ...

NEW YORK – South Korean diagnostic firm Noul said Wednesday that it has inked an agreement to launch its hematology and malaria testing tools in Europe through German lab chain Limbach Group. The ...

NEW YORK — Diagnostics developer BioAffinity said on Wednesday that it has priced a $3.2 million public stock offering. According to the San Antonio-based firm, it intends to sell 4 million shares of ...

NEW YORK – Backed by $49.1 million in US federal funding, Owlstone Medical is expanding into multi-cancer early detection (MCED) testing with plans for a home test that uses breath and urine samples.

NEW YORK — OraSure Technologies said on Tuesday that its OraQuick HIV Self-Test has received a license from Health Canada for use in Canada. The point-of-care test is designed to detect HIV-1 and ...

ANAHEIM, Calif. – The Association for Diagnostics and Laboratory Medicine is reemphasizing children's health and standardization and harmonization in the coming year, outgoing president Paul Jannetto ...

NEW YORK – New data published in JAMA Internal Medicine on Friday from MD Anderson Cancer Center researchers found that mail-in self-collection kits for human papillomavirus testing more than doubled ...

NEW YORK — Owlstone Medical, a UK-based developer of breath-based diagnostics, said Wednesday that it has closed a $27 million Series E financing round. The round was led by Ventura Capital and ...

NEW YORK – The 360Dx Top 30 fell 3 percent in October, mirroring a drop in the broader market. The Top 30 was in line with the broader markets, as the Dow Jones Industrial Average declined 1 percent, ...

NEW YORK – Backed by promising results from a recent small study, Arima Genomics believes that its Hi-C lymphoma assay can eventually replace fluorescence in situ hybridization (FISH)-based tests to ...